DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. (DMAC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DMAC · as of Jun 8, 2026
Key Statistics
Explore DiaMedica Therapeutics Inc. Data
dmac stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 100.0%
The DMAC analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $8.33, representing +48.48% upside from the current price of $5.61.
Competitors & Peers
dmac competitorsDMAC
ALT
ANNX
DBVT
DRTS
DSGNStock Performance
Full HistoryAbout DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders. Its primary drug candidate, DM199, …
what is diamedica therapeutics inc. · dmac stock overview · diamedica therapeutics inc. company profile · who is diamedica therapeutics inc. ceo · dmac NASDAQ · diamedica therapeutics inc. headquarters · diamedica therapeutics inc. business segments
About Stock Overview & Key Data
DiaMedica Therapeutics Inc. (DMAC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 3, 2012. As of the latest trading session, DMAC stock price is $5.61, with a market capitalization of $302.3M. The stock has returned +37.50% over the past 12 months and -29.52% year-to-date.
According to 6 Wall Street analysts, the consensus rating for DiaMedica Therapeutics Inc. stock is Buy, with an average 12-month price target of $8.33. In fiscal year 2025, DiaMedica Therapeutics Inc. reported revenue of — and net income of -$32.8M. For detailed data — including DiaMedica Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, DiaMedica Therapeutics Inc. (DMAC) stock price is $5.61. The stock is traded on NASDAQ under the ticker symbol DMAC. The 52-week range is $3.48 – $10.42.